Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic
An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown
1 other identifier
observational
150
1 country
1
Brief Summary
In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2020
CompletedFirst Submitted
Initial submission to the registry
May 25, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJuly 22, 2020
July 1, 2020
1.1 years
May 25, 2020
July 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Oncology patients
To focus on basic issues encountered by oncology patients such as transportation, medical facility, healthcare support, disease apprehension etc
4-8 weeks
Eligibility Criteria
The study population will comprise all the cancer patients who are registered in the Max Superspeciality hospital, Patparganj between Nov 1st 2019 to Jan 31st 2020
You may qualify if:
- Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020
- Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre
New Delhi, 110092, India
Study Officials
- PRINCIPAL INVESTIGATOR
Geeta Kadayaprath
Max Hospital, Patparganj
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2020
First Posted
May 28, 2020
Study Start
May 9, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
July 22, 2020
Record last verified: 2020-07